Study Stopped
No patient enrolled
Quality of Life and Psycological Evaluation of Patients Affected by Head and Neck Cancer
Quality of Life and Psychological Evaluation of Patients Affected by Head and Neck Cancer Treated With Curative Intent: Multicentric Prospective Study
1 other identifier
observational
N/A
1 country
1
Brief Summary
The prospective trial is to describe the quality of life and psychological effects in patients with head and neck tumor receiving curative intent treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 2, 2016
CompletedFirst Posted
Study publicly available on registry
December 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedOctober 24, 2018
October 1, 2018
1.3 years
December 2, 2016
October 23, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of life and psychological effetcs evaluated by patient reported outcome (PRO)
18 months
Study Arms (1)
Head and Neck patients
Patients affected by squamous cell carcinoma of head and neck (oral cavity, larynx, pharynx and hypopharynx) with no metastasis
Interventions
Treatment consists of Intensity Modulated Radiation Therapy (until 2.2 Gy) with a total dose of 50-66 Gy in post-operative setting and 66-72 Gy in radical setting.
Eligibility Criteria
Patients affected by head and neck tumor
You may qualify if:
- Squamous cell carcinoma of head and neck (oral cavity, larynx, pharynx and hypopharynx) in non-metastatic staging;
- curative intent treatment (radiation therapy associated or not to chemotherapy; surgery associated or not to post-operative radiotherapy and chemotherapy);
- performance status \< 2;
- age ≥ 18 years;
- good knowledge of italian language;
- written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Michele Tedeschilead
Study Sites (1)
Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
Study Officials
- STUDY CHAIR
Ciro Franzese, MD
Humanitas Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
December 2, 2016
First Posted
December 6, 2016
Study Start
November 1, 2016
Primary Completion
February 1, 2018
Study Completion
February 1, 2018
Last Updated
October 24, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share